HeartBeam, Inc. (BEAT) vs Grace Therapeutics, Inc. (GRCE)

A side-by-side comparison of HeartBeam, Inc. and Grace Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
HeartBeam, Inc. logo
BEAT
HeartBeam, Inc.
$33M
$0.60HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
Grace Therapeutics, Inc. logo
GRCE
Grace Therapeutics, Inc.
$34M
$2.11HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT

Total return — BEAT vs GRCE

growth of $100 · dividends reinvested · last 2y
BEAT -71.8% (-46.9%/yr)GRCE -31.6% (-17.3%/yr)GRCE compounded faster over this window
50100150Start $10020252026$28$68
BEAT GRCE

BEAT vs GRCE: by the numbers

  • •GRCE is the larger company ($34M vs $33M market cap).

Metrics side by side

Valuation

MetricBEATGRCE
P/B ratio4.080.71

Profitability

MetricBEATGRCE
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-248.21%-44.50%
ROIC-249.58%-52.61%

Go deeper

Full BEAT analysisFull GRCE analysisInteractive comparison tool

Dig into the metrics

HeartBeam ROEGrace Therapeutics ROEHeartBeam operating marginGrace Therapeutics operating marginHeartBeam revenue growthGrace Therapeutics revenue growthHeartBeam free cash flowGrace Therapeutics free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.